BIOGRAPHY
Professor Carsten Flohr MA MPhil MSc DHSR DLSHTM PhD FRCP FRCPCH Chair in Dermatology & Population Health Science St. John’s Institute of Dermatology Guy’s & St Thomas’ Hospitals and King’s College London Professor Flohr holds the Chair in Dermatology and Population Health Science at St John’s Institute of Dermatology, King’s College London. He is also Consultant Dermatologist and R&D Lead at Guy’s & St Thomas’ NHS Foundation Trust. Carsten Flohr was the first UK National Institute for Health Research (NIHR) Clinician Scientist in Dermatology (2009-2014) and the first UK dermatologist to be awarded a Career Development Fellowship from the NIHR (2014-2019). He has a particular interest in novel methods of atopic dermatitis (AD) prevention (early life risk factors), the role of the microbiome in AD, how AD links in with food allergies (transcutaneous sensitisation) and therapeutics, especially in severe AD. Carsten Flohr co-led the landmark Enquiring About Tolerance (EAT) trial (NEJM 2016) and was Chief Investigator of the TREatment of severe eczema in children Trial (TREAT), funded by the UK Department of Health, which compared cyclosporine with methotrexate in children with recalcitrant AD. He leads the UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR), as well as the European Dream-To-Treat-AD project, which brings together 5 European atopic dermatitis systemic therapy registers. In addition, Professor Flohr’s department investigates how food allergies develop through the skin in an European Union H2020-funded consortium (TRANS-FOODS) coordinated by him. Carsten Flohr also directs the Global Atopic Dermatitis Atlas (GADA) project. He has published widely in high impact journals, including Nature journals, the Lancet, and the New England Journal of Medicine. Prof Flohr is a Founding Director of the International Eczema Council and Past President of the British Society of Paediatric Dermatology, as well as an Honorary Member of the French Society of Dermatology and Venereology for his achievements in dermatology.
SESSIONS
HANDOUTS
DISCLOSURES
Almirall – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Incyte – Consultant (1099 relationship)(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi/Regeneron – Speaker(Honoraria);